1. Home
  2. Labeler Index
  3. Incyte Corporation
  4. 73535-208
  5. NDC Package Code: 73535-208-01 Monjuvi

NDC Package 73535-208-01 Monjuvi

Tafasitamab-cxix Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
73535-208-01
Package Description:
1 VIAL in 1 CARTON / 5 mL in 1 VIAL
Product Code:
73535-208
Proprietary Name:
Monjuvi
Non-Proprietary Name:
Tafasitamab-cxix
Substance Name:
Tafasitamab
Usage Information:
MONJUVI, in combination with lenalidomide, is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT).This indication is approved under accelerated approval based on overall response rate [see Clinical Studies (14)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
11-Digit NDC Billing Format:
73535020801
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Incyte Corporation
Dosage Form:
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route(s):
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s):
TAFASITAMAB 200 mg/5mL
Sample Package:
No
FDA Application Number:
BLA761163
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
08-05-2020
End Marketing Date:
11-30-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 73535-208-01 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
73535020801J9349Inj., tafasitamab-cxix2 MG11100100

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 73535-208-01?

The NDC Packaged Code 73535-208-01 is assigned to a package of 1 vial in 1 carton / 5 ml in 1 vial of Monjuvi, a human prescription drug labeled by Incyte Corporation. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

Is NDC 73535-208 included in the NDC Directory?

Yes, Monjuvi with product code 73535-208 is active and included in the NDC Directory. The product was first marketed by Incyte Corporation on August 05, 2020.

What is the NDC billing unit for package 73535-208-01?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

What is the 11-digit format for NDC 73535-208-01?

The 11-digit format is 73535020801. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-273535-208-015-4-273535-0208-01